CLCM
Crawford Lake Capital Management Portfolio holdings
AUM
$32M
This Quarter Return
+12.3%
1 Year Return
+12.29%
3 Year Return
+171.37%
5 Year Return
+515.54%
10 Year Return
–
AUM
$263M
AUM Growth
+$263M
(+25%)
Cap. Flow
+$38M
Cap. Flow
% of AUM
14.45%
Top 10 Holdings %
Top 10 Hldgs %
51.57%
Holding
113
New
41
Increased
6
Reduced
8
Closed
31
Top Buys
| 1 |
Citigroup
C
|
$14.7M |
| 2 |
NVIDIA
NVDA
|
$11.4M |
| 3 |
Apple
AAPL
|
$11M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$10.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$8.54M |
Top Sells
| 1 |
Alibaba
BABA
|
$14.6M |
| 2 |
Cleveland-Cliffs
CLF
|
$13.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$10.1M |
| 4 |
Groupon
GRPN
|
$7.03M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$6.77M |
Sector Composition
| 1 | Technology | 32.13% |
| 2 | Healthcare | 21.38% |
| 3 | Communication Services | 18.21% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Oracle
ORCL
$635B
| $35M | 7.73% | 697,313 -24,138 | -3% | -$1.21M |
|
|
2
Alibaba
BABA
$322B
| $15.9M | 3.52% | 113,076 -103,719 | -48% | -$14.6M |
|
|
3
Citigroup
C
$178B
| $14.7M | 3.25% | +219,964 | New | +$14.7M |
|
|
RHT
4
DELISTED
Red Hat Inc
RHT
| $11.9M | 2.63% | 124,359 +40,786 | +49% | +$3.91M |
|
|
5
NVIDIA
NVDA
$4.24T
| $11.4M | 2.51% | +78,625 | New | +$11.4M |
|
|
6
Apple
AAPL
$3.45T
| $11M | 2.43% | +76,247 | New | +$11M |
|
|
LOXO
7
DELISTED
Loxo Oncology, Inc
LOXO
| $10.4M | 2.31% | +130,151 | New | +$10.4M |
|
8
NetEase
NTES
$86.2B
| $8.72M | 1.93% | 29,000 +3,087 | +12% | +$928K |
|
|
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.54M | 1.89% | +91,191 | New | +$8.54M |
|
|
TWTR
10
DELISTED
Twitter, Inc.
TWTR
| $8M | 1.77% | +447,509 | New | +$8M |
|
11
JPMorgan Chase
JPM
$829B
| $7.31M | 1.62% | +80,000 | New | +$7.31M |
|
|
MNDT
12
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $7.23M | 1.6% | +475,288 | New | +$7.23M |
|
13
Advanced Micro Devices
AMD
$264B
| $7.19M | 1.59% | 575,800 +339,500 | +144% | +$4.24M |
|
14
Meta Platforms (Facebook)
META
$1.86T
| $6.95M | 1.54% | +46,000 | New | +$6.95M |
|
15
Novartis
NVS
$245B
| $6.29M | 1.39% | +75,335 | New | +$6.29M |
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $5.1M | 1.13% | +110,929 | New | +$5.1M |
|
17
Weibo
WB
$2.81B
| $5.02M | 1.11% | +75,488 | New | +$5.02M |
|
18
Lumentum
LITE
$9.28B
| $4.85M | 1.07% | 85,000 +42,184 | +99% | +$2.41M |
|
19
Universal Display
OLED
$6.59B
| $4.7M | 1.04% | 43,000 +2,655 | +7% | +$290K |
|
20
Akebia Therapeutics
AKBA
$833M
| $4.65M | 1.03% | +323,874 | New | +$4.65M |
|
21
Bank of America
BAC
$376B
| $4.12M | 0.91% | +170,000 | New | +$4.12M |
|
|
BIVV
22
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $3.9M | 0.86% | +64,891 | New | +$3.9M |
|
23
Bausch Health
BHC
$2.74B
| $3.84M | 0.85% | +222,000 | New | +$3.84M |
|
24
FMC
FMC
$4.88B
| $3.7M | 0.82% | 50,606 +21,454 | +74% | +$1.57M |
|
25
Trade Desk
TTD
$26.7B
| $3.52M | 0.78% | 70,305 -4,284 | -6% | -$215K |
|